No specific biological drug target

The designation "No specific biological drug target" is used in pharmacological databases like ChEMBL to categorize therapeutic agents that do not exert their effects by binding to a specific protein, such as a receptor or enzyme (ChEMBL, 2024). Instead, these agents function through non-specific physical or chemical processes. For example, antacids like aluminum hydroxide work by chemically neutralizing gastric acid (StatPearls, 2023), while osmotic diuretics like mannitol create a physical osmotic gradient to promote diuresis (StatPearls, 2023). Other examples include surfactants like simethicone, which alter the surface tension of gas bubbles (PubChem, 2024), and adsorbents like activated charcoal. Because these substances lack a defined molecular target, they often require higher therapeutic doses and may have broad physiological effects rather than targeted cellular responses. This classification is critical for biotech analysts to identify drugs that fall outside the paradigm of molecularly targeted therapy (NCBI, 2022). It serves as a necessary category for compounds that achieve clinical efficacy through systemic physiological modulation rather than discrete molecular interaction.

Other names

Non-specific targetNon-molecular targetUnknown targetNon-specific mechanism

Therapeutic effects are achieved through physical or chemical interactions, such as the neutralization of gastric acid by basic salts, the creation of osmotic gradients, or surfactant activity, rather than through binding to a specific protein target (StatPearls, 2023; ChEMBL, 2024).